Solara Active Pharma Sciences: Board Meeting Outcome for Outcome Of The Rights Issue Committee Meeting

Solara Active Pharma Sciences Limited has informed the Exchange that the Rights issue committee members at its meeting held on March 24 2026 has approved the making of Second & Final call of ? 112.50/- per equity shares (? 3.00/- towards face value and ? 109.50/- towards securities premium) per Rights Share in respect of partly paid Rights Shares and Fixed the Record date as April 02 2026 for the same.